New vaccine trial aims to shield frontline workers from deadly mpox
NCT ID NCT02977715
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested the JYNNEOS smallpox vaccine in 1,600 healthcare workers in the Democratic Republic of the Congo who are at high risk of catching mpox. The goal was to see if the vaccine can prevent mpox infection and is safe to use. Participants received the vaccine and were monitored for infections, side effects, and immune responses.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MONKEYPOX VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tshuapa site
Boende, Tshuapa, Democratic Republic of the Congo